Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 12 Nov 2025 | Veronica Manfredi Director | Meeting with Fresenius on the recast Urban Wastewater Treatment Directive (UWWTD) | — |
| 12 Nov 2025 | Veronica Manfredi Director | Meeting with Fresenius on the recast Urban Wastewater Treatment Directive | SRC |
| 12 Nov 2025 | Veronica Manfredi Director | Meeting with Fresenius on the recast Urban Wastewater Treatment Directive (UWWTD) | SRC |
| 12 Nov 2025 | Veronica Manfredi Director | Meeting with Fresenius on the recast Urban Wastewater Treatment Directive | — |
| 04 Nov 2025 | Estelle Goeger Cabinet member | Overview of the Commission's Single Market Strategy. | — |
| 04 Nov 2025 | Estelle Goeger Cabinet member | Overview of the Commission's Single Market Strategy. | SRC |
| 05 Sept 2025 | Sacha Halphen Cabinet member | - Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EU | — |
| 05 Sept 2025 | Sacha Halphen Cabinet member | - Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EU | SRC |
| 05 Sept 2025 | Stéphane Séjourné Executive Vice-President | - Compétitivité des entreprises - Marché intérieur - Protection de la souveraineté et du pouvoir d’achat - Relation US/EU | SRC |
| 03 Jul 2025 | Rainer Becker Director | Exchange of views on the upcoming Biotech Act | SRC |
| 03 Jul 2025 | Rainer Becker Director | Exchange of views on the upcoming Biotech Act | — |
| 22 May 2025 | Jan Ceyssens Cabinet member | Discussions on Urban Wastewater Treatment Directive (UWWTD) | — |
| 22 May 2025 | Jan Ceyssens Cabinet member | Discussions on Urban Wastewater Treatment Directive (UWWTD) | SRC |
| 05 Mar 2024 | Michael Hager Cabinet member | Strengthen Europe's critical sectors | SRC |
| 05 Mar 2024 | Michael Hager Cabinet member | Strengthen Europe's critical sectors | — |
Mission & Goals
Fresenius is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In fiscal year 2025, Fresenius generated €22.5 billion in annual revenue with around 178,000 employees (excluding Fresenius Medical Care). As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients. The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the Investment Company Fresenius Medical Care. Fresenius Kabi supplies healthcare products for critically and chronically ill patients Fresenius Helios is Europe’s leading private hospital operator
EU Legislative Interests
Artificial Intelligence, Biosimilars, Biomanufacturing, Chemical Regulations, Chemicals Strategy for Sustainability, Critical Infrastructure, Critical Medicines Act, Chronic Diseases, Circular Economy, Corporate Sustainability Due Dilligence, Cybersecurity, Environmental Policies, EU Biotech Act, EU Green Deal, EU Pharmaceutical Legislation, EU Trade Policy, European Cancer Plan, European Health Data Space, European Semester, Equal Pay Directive, Free Trade Agreements, Global Gateway Initiative, Global Health Policies, Health Technology Assessment, Horizon Europe Programme, Hospitals, Industrial Strategy, IP Legislation, Multiannual Financial Framework, Network and Information Security, Omnibus Proposals, Patients, Pricing and Reimbursement Policies, Public Health Policies, Raw Materials Act, REACH, Revision of Directive 2001/83/EC, Revision of Medical Device Regulation, Standardisation, Taxonomy, Waste Water, UWWTD, Zero Net Industry Act
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Fresenius SE & Co.KGaA and its consolidated subsidiaries are represented in a large number of associations worldwide. Memberships of Fresenius SE & Co.KGaA in organisations that would be relevant for the register are as follows: - MedTech Europe - Pharma Deutschland e. V. - Bundesverband Medizintechnologie e. V. (BVmed) - Verband der Chemischen Industrie e.V. (VCI) - Blood Transfusion Association - German Health Alliance (GHA) - Deutsches Institut für Normung e. V. (DIN) - Medicines for Europe - Specialised Nutrition Europe - Medical Nutrition International Industry Association - International Special Dietary Foods Industries
Organisation Members
Fresenius Kabi AG, Helios Kliniken GmbH https://www.fresenius.com/de/konzern-im-ueberblick